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Abstract
Noninvasive direct vessel wall (plaque) imaging may provide a good opportunity to study unique aspects of ather-
osclerotic lesions in different populations. The article published by Esposito et al. provides new insights into our
understanding of diabetic atherosclerotic vascular disease by using direct plaque imaging techniques. The findings
from this article call for attention to more in vivo imaging to understand the nature of high-risk atherosclerosis,
especially in prospective studies in diabetic patients.
See research article: http://www.biomedcentral.com/1471-2342/10/27/abstract
In an article published this month in BMC Medical
Imaging, Esposito et al. [1] provide an important contri-
bution to our understanding of diabetic atherosclerotic
vascular disease by applying direct atherosclerotic pla-
que imaging by magnetic resonance imaging (MRI) to a
large group of patients with and without diabetes. In
this study, the authors observed an association between
diabetes and high-risk carotid plaque characteristics.
The authors also observed that carotid plaques may be
more in danger of rupturing during endarterectomy
than plaques of nondiabetic patients, leading to a greater
propensity for distal embolization into the cerebral
vasculature.
The effect of diabetes on the atherosclerotic process has
been well studied in the past, with multiple studies
demonstrating marked increases in the presence of subcli-
nical atherosclerosis across all multiple vascular beds
in diabetic patients [2-5]. However, most conventional
imaging modalities such as coronary artery calcium and
carotid intimal media thickness (IMT) provide quantitative
measures of atherosclerosis with limited insight into well-
established complexities of the atherosclerotic process,
such as the formation of complex, high-risk plaques [6].
More recently, novel MRI-based techniques have been
established which can identify high-risk carotid plaques
through the detection of major tissue components such
as lipid-rich necrotic core, intraplaque hemorrhage and
calcium [7-9]. These techniques represent a reliable
measure of these plaque features as compared to histol-
ogy and have been shown to represent significant deter-
minants of both clinical (i.e., stroke) [10] and subclinical
(i.e., plaque progression) events [11]. Although these
techniques have been well studied in clinical popula-
tions, there has been relatively little application of these
imaging techniques to diabetic atherosclerotic disease in
particular. Therefore, the findings by Esposito and
colleagues [1] represent an important contribution to
our understanding of the topic, suggesting that carotid
a t h e r o s c l e r o s i si nd i a b e t i cp a t i e n t si sq u a l i t a t i v e l y
distinct.
There are mechanistic observations to suggest the
unique characteristics of diabetic atherosclerosis [12-14].
For example, high levels of circulating glucose have
been associated with a decrease in nitric oxide availabil-
ity in the endothelium, thereby translating into athero-
sclerotic plaque formation [15]. Additional observations
have suggested that an increased formation of reactive
oxygen species in diabetic patients leads to downstream
changes in the formation of inflammatory proteins [16].
Thus, there is biologic plausibility to the argument that
diabetic atherosclerosis might in fact be qualitatively dif-
ferent from nondiabetic atherosclerosis.
Some prior studies [17], but not all [18], have observed
significant differences in the characteristics of athero-
sclerotic plaque among individuals with diabetes as com-
pared to individuals without diabetes. For example, in a
study of 270 autopsy cases, the presence of diabetes was
associated with larger necrotic cores, a greater burden of
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rupture [17]. However, the presence of diabetes was also
associated with marked differences in the overall quanti-
tative burden of atherosclerosis, suggesting the impor-
tance of both quantitative and qualitative differences in
diabetic atherosclerotic disease.
Prior studies in the carotid MRI literature also observed
the strong correlation between the quantitative burden of
atherosclerosis and high-risk plaque features such as lipid-
rich necrotic core and intraplaque hemorrhage. For exam-
ple, in the ARIC Carotid MRI study [19], the prevalence of
lipid-rich necrotic core was relatively common among
participants with a carotid wall thickness of ≥1.5 mm (42%
prevalence), in contrast to those participants with a wall
thickness of <1.5 mm (0.6% prevalence). Similar findings
were observed in a separate study demonstrating the
importance of plaque burden in the development of intra-
plaque hemorrhage [20].
Thus, the strong correlation between plaque burden
and high-risk plaque characteristics observed in other
studies is important to consider in evaluating the cur-
rent study by Esposito and colleagues [1]. Although the
presence of diabetes was associated with a higher preva-
lence of high-risk plaque characteristics, the authors
provided no information on the overall plaque burden
between these two groups (i.e., maximum wall thick-
ness). Without these data, our ability to interpret these
findings is limited.
Finally, the Esposito et al.[ 1 ]s t u d ya l s oo b s e r v e da n
association between diabetes and the prevalence of distal
embolization in the cerebral vasculature after carotid
endarterectomy, suggesting the hypothesis that the pre-
sence of diabetes might have clinical implications for
the treatment of carotid disease. Several cautionary
points should be noted in the interpretation of these
results. First, diabetes was significantly associated with a
symptomatic presentation of carotid artery disease (39%
vs. 22.5%; P = 0.02). Although the authors did adjust for
the presence of symptoms in their analyses, the small
number of patients undergoing surgery (N = 72) results
in a point estimate with wide confidence intervals which
should be interpreted with caution. Second, the authors
do not include age as a covariate in these analyses.
Because we are not given the association between age
and diabetes among those referred for surgery, the rela-
tive importance of age and diabetes in influencing these
findings cannot be adequately assessed.
In summary, because direct plaque imaging by MRI can
characterize both lesion size and composition, this techni-
que represents a unique opportunity to broaden our
understanding of atherosclerotic vascular disease in differ-
ent clinical populations (i.e., diabetes). Such studies are
not only safe and feasible [21] but also can be extended
into prospective study designs which are critically needed
to improve our understanding of atherosclerosis progres-
sion and the development of high-risk lesions.
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